Status:
COMPLETED
Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries
Lead Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Conditions:
Clostridium Difficile Infection
Eligibility:
All Genders
Brief Summary
The aim of this study is to conduct an Asia-Pacific, multi-center, prospective observational study to characterize patients with CDI as well as to understand treatment and management of the disease.
Eligibility Criteria
Inclusion
- Patients with a confirmed diagnosis of CDI, as documented by diarrheal symptoms and positive stool test result for CDT or toxigenic C. difficile, or colonoscopic findings of PMC
- Patients and/or legal guardian willing to provide informed consent and/or informed assent or data release, according to local regulations
Exclusion
- Patients with diarrheal symptoms caused by bacteria other than C. difficile, such as Salmonella, Campylobacter, Vibrio, Shigella, and Escherichia coli.
Key Trial Info
Start Date :
March 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT02223715
Start Date
March 1 2014
End Date
January 1 2015
Last Update
October 17 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanto Region, Japan